Billionaire-led funds held stakes in Viatris (VTRS) and BioCryst (BCRX) at the end of Q2
A total of 23 billionaire-led funds held stakes in Viatris (NASDAQ: VTRS) at the end of the second quarter, while 22 funds held stakes in BioCryst (NASDAQ: BCRX). Viatris's Q2 revenue rose about 4.9% year over year, and management raised its fiscal 2026 guidance across all key metrics. The FDA also approved Gwyn Lo, a once-weekly contraceptive patch from Viatris, which the company plans to launch later in fiscal 2026.
No AI analysis yet. Tap the "AI Analysis" button above to generate one now.
Disclaimer: This content reflects the author's personal views only and does not constitute investment advice.
24H Trending
-
1
How to Evaluate the Security of Virtual Currency Trading Platforms
-
2
Terra Classic (LUNC) Market Review: From Collapse to Community-Driven Recovery
-
3
Turkey Confirms Hex Founder Richard Heart Arrested, Police Seize $7.15M Cash and 6 Cold Wallets
-
4
Ledger co-founder Bacca reacts to AI Claude's ECDSA origins discovery, saying 'Checkmate Satoshi'
-
5
Syscoin (SYS) Project Analysis and Technical Status
-
6
Ethereum GPU Mining Post-Merge: Transition and Profitability Challenges
-
7
A New York Times investigation alleges that a U.S. embassy aide blocked a report on the deaths of nine Americans in the West Bank, possibly to protect Israeli interests.
-
8
Japan will push to sign its first economic agreement with Bangladesh, aiming to eliminate tariffs on Japanese textile imports.
-
9
Saylor retweeted a post explaining the evolution of his daily dividend philosophy: from quarterly to daily.
-
10
Starpad (SRP) Project Analysis and Market Overview
Markets Today
Recommended Reading







